Skip to main content
Clinical Trials/CTRI/2024/02/063327
CTRI/2024/02/063327
Not Yet Recruiting
Phase 3

Effect of Sound Wave Therapy along with Ayurevda for the Treatment of Diabetes Mellitus Type-2. A pilot Study - NI

Patanjali Research Foundation0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Patanjali Research Foundation
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Total treatment period is greater than seven days.
  • Subjects willing to participate and give consent for the study.
  • Capability for complete compliance and completion of follow\-up.

Exclusion Criteria

  • Patients on insulin or with severe complications including proliferative diabetic retinopathy,
  • peripheral neuropathy, diabetic nephropathy with CKD stages 4 and 5 and active diabetic foot ulcer.
  • A cardiovascular event requiring hospitalization in the last 6 months
  • Serious cognitive impairment including subjects with malignancies
  • The subjects are not willing to provide Informed Consent
  • Pregnant and lactating women
  • Patient having HbA1C values above the mentioned, and FBS above the mentioned inclusion criteria are excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials